Optical Method for the Diagnosis of Amyloid Diseases, A Biomarker Technology

Summary of the technology

A spectroscopic, optical method for early detection of amyloid fibril formation in cerebrospinal fluid, as a non-destructive diagnostic tool for early detection of amyloid diseases.
The core recognition motif of A? peptide is the di-phenylalanine (FF) element, which has been found to self-assemble into nanostructures and Quantum Dots. Similar structures have been observed in amyloid fibrils as well, an example below.
The amyloid structures are believed to have unique spectrums of optical absorption, photoluminescence, electroluminescence, injection luminescence, thermoluminescence, similar to those of the measured spectrums of self assembling Peptide Nanostructures. Such a distinct, concentration-sensitive measurement, can be used a biomarker for such diseases.
Project ID : 5-2013-459

RAMOT at Tel Aviv University Ltd.

Details of the Technology Offer

The Technology
A spectroscopic, optical method for early detection of amyloid fibril formation in cerebrospinal fluid, as a non-destructive diagnostic tool for early detection of amyloid diseases.
The core recognition motif of Aβ peptide is the di-phenylalanine (FF) element, which has been found to self-assemble into nanostructures and Quantum Dots. Similar structures have been observed in amyloid fibrils as well, an example below.
The amyloid structures are believed to have unique spectrums of optical absorption, photoluminescence, electroluminescence, injection luminescence, thermoluminescence, similar to those of the measured spectrums of self assembling Peptide Nanostructures. Such a distinct, concentration-sensitive measurement, can be used a biomarker for such diseases.

The Need
There are at least 20 distinct human diseases that are associated with amyloid fibril formation: The most common and the most studied is Alzheimer’s disease, with a defined well known fibrils structure made of amyloid-β peptide (Aβ). A partial list of other amyloid diseases includes type II diabetes, amyloidosis, medullary carcinoma of the thyroid and prion diseases. The naturally self-assembled protein fibrils, associated with such neurodegenerative diseases are widely researched in the last century, however, an early, direct, non-dementia, diagnostic tool has not yet been found.

Advantages
1. High concentration sensitivity due to a significant change in the optical properties of the oligomers and amyloid fibrils with their assembly which correlates to the disease progression.
2. The method can be applied for drugs assays against amyloid diseases for testing the drug potency to dissolve the amyloid fibrils.

Patents
US and EP patent applications WO 2010/038228.

Supporting Publications
1. Amdursky, N., Molotskii, M., Gazit, E., and Rosenman, G. (2009) Self-Assembled Bioinspired Quantum Dots: Optical Properties. Appl. Phys Lett. 94, 261907
2. Amdursky, N., Molotskii, M., Aronov, D., Adler-Abramovich, L., Gazit, E., and Rosenman, G. (2009) Blue Luminescence Based on Quantum Confinement at Peptide Nanotubes. Nano. Lett. 9, 3111-3115
3. Amdursky, N., Gazit E., and Rosenman, G. (2010) Quantum Confinement in Self-Assembled Bioinspired Peptide Hydrogels. Adv. Mater. 22, 2311-2315
4. Amdursky, N., Gazit, E., and Rosenman G. (2012) Formation of low-dimensional crystalline nucleus region during insulin amyloidogenesis process, Biochem. Biophys. Res. Commun. 419, 232-237

Project manager

Elisha Natan
Director BD

Project researchers

Gil Rosenman
T.A.U Tel Aviv University, Engineering
Physical Electronics

Ehud Gazit
T.A.U Tel Aviv University, Life Sciences
Molecular Microbiology-Biotechnology

Related Keywords

  • Medicine, Human Health
  • Diagnostics, Diagnosis
  • Medical Technology / Biomedical Engineering
  • Biology / Biotechnology
  • Cellular and Molecular Biology Technology
  • Microbiology Technology
  • Genome Research
  • Bioinformatics Technology
  • Micro- and Nanotechnology related to Biological sciences
  • Microbiology Market
  • Micro- and Nanotechnology related to Biological sciences
  • Biochemistry / Biophysics Market
  • Stem cells and biobanks
  • Cellular and Molecular Biology Market
  • Bioinformatics Market
  • Diagnostic
  • Medical imaging
  • In-vitro diagnostics
  • Therapeutic
  • Other Medical/Health Related
  • Other medical/health related (not elsewhere classified)
  • Clinical Medicine
  • Medical equipment
  • Life Sciences and Biotechnology
  • Research / Development tools
  • medical devices
  • In Vitro Diagnostics
  • medical devices
  • Diagnostic Instruments

About RAMOT at Tel Aviv University Ltd.

Ramot is Tel Aviv University's (TAU) technology transfer company and its liaison to industry, bringing promising scientific discoveries made at the university to industry's attention. The company provides the legal and commercial frameworks for inventions made by TAU faculty, students and researchers, protecting discoveries with patents and working jointly with industry to bring scientific innovations to the market.

RAMOT at Tel Aviv University Ltd.

Never miss an update from RAMOT at Tel Aviv University Ltd.

Create your free account to connect with RAMOT at Tel Aviv University Ltd. and thousands of other innovative organizations and professionals worldwide

RAMOT at Tel Aviv University Ltd.

Send a request for information
to RAMOT at Tel Aviv University Ltd.

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support